• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction: Circulating Tumor cells and multiple indicators combined to identify the risk of poorer prognosis in patients with resected non-small cell lung cancer.

作者信息

Song Jinghan, Ye Xiong, Peng Qianqian, Ying Xinnan, Xiao Hui

机构信息

Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

School of Clinical Medicine, Shanghai University of Medicine & Health Sciences, Shanghai, China.

出版信息

BMC Cancer. 2024 Dec 11;24(1):1511. doi: 10.1186/s12885-024-13306-2.

DOI:10.1186/s12885-024-13306-2
PMID:39663518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11636008/
Abstract
摘要

相似文献

1
Correction: Circulating Tumor cells and multiple indicators combined to identify the risk of poorer prognosis in patients with resected non-small cell lung cancer.更正：循环肿瘤细胞与多项指标联合用于识别接受手术切除的非小细胞肺癌患者预后较差的风险。
BMC Cancer. 2024 Dec 11;24(1):1511. doi: 10.1186/s12885-024-13306-2.
2
Circulating Tumor cells and multiple indicators combined to identify the risk of poorer prognosis in patients with resected non-small cell lung cancer.循环肿瘤细胞与多项指标联合用于识别接受手术切除的非小细胞肺癌患者预后较差的风险。
BMC Cancer. 2024 Dec 3;24(1):1491. doi: 10.1186/s12885-024-13245-y.
3
CD3, CD8, IFN-γ, tumor and stroma inflammatory cells as prognostic indicators for surgically resected SCLC: evidences from a 10-year retrospective study and immunohistochemical analysis.CD3、CD8、IFN-γ、肿瘤和基质炎症细胞作为 SCLC 手术切除患者的预后指标：来自 10 年回顾性研究和免疫组织化学分析的证据。
Clin Exp Med. 2024 May 15;24(1):99. doi: 10.1007/s10238-024-01329-9.
4
Circulating CD14+CD204+ cells predict postoperative recurrence in non-small-cell lung cancer patients.循环 CD14+CD204+ 细胞可预测非小细胞肺癌患者术后复发。
J Thorac Oncol. 2014 Feb;9(2):179-88. doi: 10.1097/JTO.0000000000000044.
5
The Presence of Small-Size Circulating Tumor Cells Predicts Worse Prognosis in Non-Small Cell Lung Cancer Patients.小尺寸循环肿瘤细胞的存在预示非小细胞肺癌患者预后更差。
Arch Pathol Lab Med. 2025 Jan 1;149(1):39-49. doi: 10.5858/arpa.2023-0455-OA.
6
Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer.非小细胞肺癌和小细胞肺癌中免疫状态的多样性和异质性。
PLoS One. 2021 Dec 2;16(12):e0260988. doi: 10.1371/journal.pone.0260988. eCollection 2021.
7
The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.切除的非小细胞肺癌中单种和多种癌症相关体细胞突变的预后影响。
Lung Cancer. 2018 Sep;123:22-29. doi: 10.1016/j.lungcan.2018.06.023. Epub 2018 Jun 19.
8
Positive Correlation Between the Number of Circulating Tumor Cells in the Pulmonary Vein and Tumor Spread Through Air Spaces in Resected Non-small Cell Lung Cancer.肺静脉循环肿瘤细胞数量与切除非小细胞肺癌中空气空间肿瘤扩散的正相关性。
Anticancer Res. 2021 Nov;41(11):5499-5505. doi: 10.21873/anticanres.15363.
9
Circulating tumor cells in peripheral and pulmonary venous blood predict poor long-term survival in resected non-small cell lung cancer patients.外周静脉和肺静脉循环肿瘤细胞可预测非小细胞肺癌患者切除术后的长期生存不良。
Sci Rep. 2017 Jul 10;7(1):4971. doi: 10.1038/s41598-017-05154-x.
10
Prognostic significance of TAZ expression in resected non-small cell lung cancer.TAZ 表达在可切除非小细胞肺癌中的预后意义。
J Thorac Oncol. 2012 May;7(5):799-807. doi: 10.1097/JTO.0b013e318248240b.

本文引用的文献

1
Circulating Tumor cells and multiple indicators combined to identify the risk of poorer prognosis in patients with resected non-small cell lung cancer.循环肿瘤细胞与多项指标联合用于识别接受手术切除的非小细胞肺癌患者预后较差的风险。
BMC Cancer. 2024 Dec 3;24(1):1491. doi: 10.1186/s12885-024-13245-y.